
Joseph Walker
Reporter at The Wall Street Journal
Reporter at The Wall Street Journal @WSJ, covering pharma and biotech. Hello in there, hello.
Articles
-
1 week ago |
wsj.com | Joseph Walker
Republican budget cutters are targeting state taxes on hospitals and nursing homes that raise federal Medicaid spendingAn obscure set of state taxes on hospitals and other health providers is in the crosshairs of congressional budget cutters because the levies can lead to higher federal spending on Medicaid. Known as provider taxes because states impose them on hospitals, nursing homes and other facilities that provide healthcare, the taxes boost a state’s budget for funding Medicaid.
-
3 weeks ago |
wsj.com | Dave Michaels |Joseph Walker
The commission has paused its lawsuit against three pharmacy-benefit managers because no current commissioners can participate in the caseThe Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after President Trump fired two of the agency’s commissioners. The FTC this week halted a lawsuit against the country’s largest drug middlemen, which negotiate drug prices for employers and insurers.
-
1 month ago |
wsj.com | Joseph Walker
March 15, 2025 9:08 am ETA new breed of drug middlemen are pushing an unusual cost-saving strategy that lets their employer clients tap a federal program meant for hospitals that serve the poor. The government program, known as 340B, allows hospitals that care for many uninsured and low-income patients to purchase outpatient medicines at steep discounts. Hospitals can pocket the savings, but they can also choose to pass the discounts on to patients at their pharmacies.
-
1 month ago |
wsj.com | Joseph Walker
Companies such as Rescription, MakoRx and Liviniti are selling pharmacy-benefit plans that save employers money by funneling workers to those 340B hospital pharmacies instead of traditional drugstores. The workers get the discounted 340B price under these plans. Hospitals participate because it expands their customer base and they receive fees for dispensing prescriptions, the companies say.
-
1 month ago |
wsj.com | Joseph Walker
Your browser does not support the audio tag. 00:00 / 01:45This article is in your queue. Not much has gone right for Walgreens Boots Alliance WBA -1.40%decrease; red down pointing triangle in the past decade.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 1K
- DMs Open
- Yes

When Medicaid recipients signed up in two states at once, insurers often got paid by both. It’s costing taxpayers billions. https://t.co/bzKEOVxgyq

Border agents are using more aggressive tactics to question visa holders, tourists https://t.co/YXo5C5vRJB via @WSJ

Malcolm X was gunned down in Manhattan 60 years ago today.

"The difference is, Malcolm X talked of hate and caused you to think of love and these politicians speak of love and make it sound like meanness." - Jimmy Breslin https://t.co/P0QPVyJT8o